These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25435424)
1. Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs. Dedinszki D; Kiss A; Márkász L; Márton A; Tóth E; Székely L; Erdődi F Cell Signal; 2015 Feb; 27(2):363-72. PubMed ID: 25435424 [TBL] [Abstract][Full Text] [Related]
2. Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A. Kiss A; Lontay B; Bécsi B; Márkász L; Oláh E; Gergely P; Erdodi F Cell Signal; 2008 Nov; 20(11):2059-70. PubMed ID: 18755268 [TBL] [Abstract][Full Text] [Related]
3. Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin. Tóth E; Erdődi F; Kiss A Anticancer Agents Med Chem; 2021; 21(9):1092-1098. PubMed ID: 32679023 [TBL] [Abstract][Full Text] [Related]
4. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases. Yan Y; Mumby MC J Biol Chem; 1999 Nov; 274(45):31917-24. PubMed ID: 10542219 [TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Boudreau RT; Conrad DM; Hoskin DW Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 1-dependent dephosphorylation of Akt is the prime signaling event in sphingosine-induced apoptosis in Jurkat cells. Thayyullathil F; Chathoth S; Shahin A; Kizhakkayil J; Hago A; Patel M; Galadari S J Cell Biochem; 2011 Apr; 112(4):1138-53. PubMed ID: 21308747 [TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
9. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703 [TBL] [Abstract][Full Text] [Related]
10. Interplay of myosin phosphatase and protein phosphatase-2A in the regulation of endothelial nitric-oxide synthase phosphorylation and nitric oxide production. Bátori R; Bécsi B; Nagy D; Kónya Z; Hegedűs C; Bordán Z; Verin A; Lontay B; Erdődi F Sci Rep; 2017 Mar; 7():44698. PubMed ID: 28300193 [TBL] [Abstract][Full Text] [Related]
11. Regulated interaction of protein phosphatase 1 and protein phosphatase 2A with phospholipase C-related but catalytically inactive protein. Sugiyama G; Takeuchi H; Nagano K; Gao J; Ohyama Y; Mori Y; Hirata M Biochemistry; 2012 Apr; 51(16):3394-403. PubMed ID: 22458807 [TBL] [Abstract][Full Text] [Related]
12. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112 [TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase-1 activation and association with the retinoblastoma protein in colcemid-induced apoptosis. Puntoni F; Villa-Moruzzi E Biochem Biophys Res Commun; 1999 Dec; 266(1):279-83. PubMed ID: 10581203 [TBL] [Abstract][Full Text] [Related]
14. The role of dual‑specificity phosphatase 1 and protein phosphatase 1 in β2‑adrenergic receptor‑mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines. Tuglu MM; Bostanabad SY; Ozyon G; Dalkiliç B; Gurdal H Mol Med Rep; 2018 Jan; 17(1):2033-2043. PubMed ID: 29257221 [TBL] [Abstract][Full Text] [Related]
15. Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. Martelli AM; Papa V; Tazzari PL; Ricci F; Evangelisti C; Chiarini F; Grimaldi C; Cappellini A; Martinelli G; Ottaviani E; Pagliaro P; Horn S; Bäsecke J; Lindner LH; Eibl H; McCubrey JA Leukemia; 2010 Apr; 24(4):687-98. PubMed ID: 20200557 [TBL] [Abstract][Full Text] [Related]
16. Okadaic acid induces phosphorylation and translocation of myosin phosphatase target subunit 1 influencing myosin phosphorylation, stress fiber assembly and cell migration in HepG2 cells. Lontay B; Kiss A; Gergely P; Hartshorne DJ; Erdodi F Cell Signal; 2005 Oct; 17(10):1265-75. PubMed ID: 16038801 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Peptide Derived from the Myosin Phosphatase Target Subunit Is a Novel Inhibitor of Protein Phosphatase-1. Kónya Z; Tamás I; Bécsi B; Lontay B; Raics M; Timári I; Kövér KE; Erdődi F Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902219 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors. Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665 [TBL] [Abstract][Full Text] [Related]
19. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840 [TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia. Mori N; Ishikawa C; Uchihara JN; Yasumoto T Curr Cancer Drug Targets; 2013 Oct; 13(8):829-42. PubMed ID: 24015987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]